Expanding the reaction toolbox for nanoscale direct-to-biology PROTAC synthesis and biological evaluation

High-throughput chemistry (HTC) and direct-to-biology (D2B) platforms allow for plate-based compound synthesis and biological evaluation of crude mixtures in cellular assays. The rise of these workflows has rapidly accelerated drug-discovery programs in the field of targeted protein degradation (TPD) in recent years by removing a key bottleneck of compound purification. However, the number of chemical transformations amenable to this methodology remain minimal, leading to limitations in the exploration of chemical space using existing library-based approaches. In this work, we expanded the toolbox by synthesising a library of degraders in D2B format. First, reaction conditions are established for performing key medicinal chemistry transformations, including reductive amination, S<sub>N</sub>Ar, palladium-mediated cross-coupling and alkylation, in D2B format. Second, the utility of these alternative reactions is demonstrated by rapidly identifying developable PROTACs for a range of protein targets.

Authors

Institutions

Publication Details

Journal
RSC Medicinal Chemistry
Published
2024-12-23
DOI
https://doi.org/10.1039/d4md00760c
Citations
17
Primary Topic
Protein Degradation and Inhibitors
Type
article
Field-Weighted Citation Impact
3.97

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Expanding the reaction toolbox for nanoscale direct-to-biology PROTAC synthesis and biological evaluation

Harry J. Shrives, Jenni Cryan, David Battersby, Rebecca Stevens et al.
17 citations
RSC Medicinal Chemistry
Protein Degradation and Inhibitors
3.97
article

Expanding the reaction toolbox for nanoscale direct-to-biology PROTAC synthesis and biological evaluation

Harry J. Shrives, Jenni Cryan, David Battersby, Rebecca Stevens, Diana Klimaszewska, Peter Stacey, John D. Harling, Glenn A. Burley, Afjal H. Miah
article en
17 citations

Abstract

High-throughput chemistry (HTC) and direct-to-biology (D2B) platforms allow for plate-based compound synthesis and biological evaluation of crude mixtures in cellular assays. The rise of these workflows has rapidly accelerated drug-discovery programs in the field of targeted protein degradation (TPD) in recent years by removing a key bottleneck of compound purification. However, the number of chemical transformations amenable to this methodology remain minimal, leading to limitations in the exploration of chemical space using existing library-based approaches. In this work, we expanded the toolbox by synthesising a library of degraders in D2B format. First, reaction conditions are established for performing key medicinal chemistry transformations, including reductive amination, S<sub>N</sub>Ar, palladium-mediated cross-coupling and alkylation, in D2B format. Second, the utility of these alternative reactions is demonstrated by rapidly identifying developable PROTACs for a range of protein targets.

RSC Medicinal ChemistryVol. 16(3)
University of Strathclyde (GB), Age UK (GB)
GlaxoSmithKline, University of Strathclyde, Society of Chemical Industry, Royal Commission for the Exhibition of 1851
Openalex Percentile: Top 5%
Protein Degradation and Inhibitors
3.97
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Expanding the reaction toolbox for nanoscale direct-to-biology PROTAC synthesis and biological evaluation — Harry J. Shrives, Jenni Cryan, et al. · RSC Medicinal Chemistry (2024) | TGRS Research Map | TGRS